$GILD (-1,15 %) Gilead Science

This is now my tenth title in the healthcare sector

Market cap € 85 bn

P/E ratio approx. 13

Continuous increase in dividends

Double-digit profit growth with constant sales

Solidly filled pipeline (https://www.gilead.com/science-and-medicine/pipeline)

and ongoing acquisitions

Buy and hold, or add more if the share price weakens.